[1]
Agrawal, N., Joanna Rongong, S.L., Halder, S., Barua, J.K., Satsangi, P., Halder, A.K. and Samanta, P. 2023. An institution-based non-randomised prospective study to estimate the efficacy and adverse effect profile of apremilast for moderate to severe refractory palmoplantar psoriasis. International Journal of Research in Dermatology. 9, 3 (Apr. 2023), 111–116. DOI:https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20231163.